POLIMAG 2 provides low-frequency, low-intensity pulsed electromagnetic fields. PEMF Therapy has been proven clinically to help improve the efficacy of medical protocols of patients with acute and chronic cardio-vascular, broncho-pulmonary, neurological, musculoskeletal, immune disorders, traumatic injuries and their complications, and post-surgical edema, pain, inflammation and promotes tissue healing.
Treats 2 patients at the same time.
Polimag 2 can vary between continuous and intermittent pulsed magnetic fields (running, spinning, pulsating), which differ in configuration, intensity, direction and speed of the magnetic field in space. With various attachments it can apply PEMF Therapy simultaneously to multiple large and small body areas.
Polimag2 – PEMF device for Medical Office
.POLIMAG 2 provides the ability to synchronize magnetotherapeutic signals with other biofeedback devices through your PC. POLIMAG 2 takes up little space and can be moved between rooms on wheels. Built-in memory allows for storage up to 8 different combinations of therapy specific to your patients. ElectroMagnetic fields generated by Polimag 2 • continuous (“fixed”) pulsing; • intermittent pulsing magnetic field; • running in a vertical plane from the top down or bottom-up; • running in a horizontal plane or a rotating magnetic field from right to left or left to right; • running on the diagonal plane. Creates the effect of simultaneous action of “running” the magnetic field in the horizontal and vertical planes •The amplitude of magnetic induction at the surface of the inductors in the mode of formation of “running” of the field can be adjusted to 2, 4, 6, 8, 10, 15, 20 mT at a frequency field pulses from 1 to 100 Hz and 25 mT at a frequency of 1 to 75 Hz mode formation of the “fixed” field – 2, 4, 6 mT at a frequency magnetic field pulses of 1 to 16 Hz. •The procedure of magnetic treatment (min) – from 5 to 30. •The duration of impulsive action and pauses between them in a discontinuous magnetic field (s) – 1 to 60 in increments of 1 sec. •Pulse frequency magnetic field (Hz) – 1 to 100 in increments of 1 Hz. •The surface temperature of radiators – less than 400C •Operation mode setup time not more than – 30 sec. •Time of continuous operation for at least 8 hours at a cyclic mode: 30 minutes – the magnetic effect, 10 minutes – a break. •Average lifetime device is not less than 5 years. The Polimag PEMF device can be adjusted for: - Configuration of the field, - Magnetic induction, - Frequency, - Exposure time, - Direction of travel of pulsed magnetic fields in space. PEMF – Pulsed ElectroMagnetic Field Therapy Devices have been used in conjunction with medical treatments for: Diseases of the nervous system: encephalopathy of different genesis, atherosclerosis, post-traumatic, toxic, vertebrobasilar insufficiency with transient disorders of cerebral circulation, neuropathy, plexopathy compression-ischemic, post-traumatic, toxic, alcohol, radiation, infection, allergic, infectious neuritis, toxic etiology, consequences of closed head brain injury, multiple sclerosis, migraine, cerebral palsy. Diseases of the circulatory system: neurocirculatory dystonia of hypertensive type, hypertension I-II A Art., Coronary heart disease with stable angina, heightening tensions I-II FC, obliterating atherosclerosis of the extremities, varicose limbs with venous insufficiency of phlebitis, thrombophlebitis; lymphostasis postoperative and post-traumatic stress. Respiratory diseases: chronic bronchitis, chronic obstructive bronchitis, acute pneumonia in the stage of resolution, chronic pneumonia in the acute stage, bronchial asthma, bronchiectasis, pulmonary tuberculosis during treatment with antibiotic therapy. Diseases of the digestive system: chronic gastrodoudenit, stomach ulcer and duodenal ulcer, chronic colitis, dyskinesia of the digestive system, chronic hepatitis, chronic pancreatitis. Diseases of the musculoskeletal system and connective tissue: osteochondrosis with vertebrogenic radiculopathy; deforming joint disease, arthritis of different etiology (rheumatoid, infectious, arthritic, psoriatic); osteoarticular tuberculosis during treatment with antibacterial drugs, firearms and the consequences of traumatic injuries of the locomotor system (fractures, dislocations of joints, damage to the menisci of the joints), inflammatory diseases and traumatic injuries of soft tissues, tendons, ligaments, joint capsule (bursitis, ligament, tenosynovitis, etc.), hematoma. Diseases of the genitourinary system: chronic pyelonephritis, chronic cystitis, a chronic inflammatory disease of female genital mutilation, chronic prostatitis. Endocrinopathy: diabetic macro-and microangiopathy, diabetic polyneuropathy. Suppurative diseases of the skin and subcutaneous tissue under a permit or after surgery: furuncle, carbuncle, abscess, septic wounds (trauma-induced, trophic, after burns and frostbite), erysipelas, chronic osteomyelitis. Immunodeficiency states, including immunodeficiency states during radiotherapy. Contraindications: tendency to bleeding, systemic blood diseases, malignant neoplasm, severe hypotension, diseases that occur with high fever, acute phase of myocardial infarction, acute phase of cerebral infarction, abscesses of skin, subcutaneous tissue, cavities before surgery, puncture of the cavity; pronounced thyrotoxicosis, pregnancy , the presence of an implanted pacemaker. The device is provided with all necessary permits, including certificates of CE and ISO. Currently, the unit “POLIMAG-02 is preparing for the testing and clinical trials. Disclaimer: This information is not intended to replace health care advice of a physician. No statements made herein are intended to diagnose or treat by this organization. POLIMAG listed with FDA as a biofeedback device. If you have pain, fatigue, discomfort or any disease, please see your doctor. Though pulsed electromagnetic field therapy devices have been evaluated and given 510(k) clearance by FDA, the POLIMAG has not yet been evaluated. POLIMAG does not cure or treat any diseases or specific conditions. It is to be used by licensed health care professionals to administer PEMF Therapy to the patients that need it. It is up to physicians to decide what are all the indications of PEMF therapy. CE and ISO approval in Europe since 1998. * FDA registration in the U.S TO LEARN MORE ABOUT POLIMAG or to ORDER POLIMAG 2 - Please Call (718) 930 – 5152 ALMAG-02 version1
Please Note: PEMF devices are not contraindicated in course of chemotherapy and radiotherapy, the presence of stents, after coronary artery bypass grafting, in the presence of titanium structures DISCLAIMER: The information provided at this website is not medical advice. Readers are encouraged to obtain the help, services and recommendations of doctors and other licensed medical practitioners. All devices on this website are certified by international certificates ISO 13485, CE 0044 and TUV Nord for design and manufacturing of electrical therapy devices. In the USA these systems have not been granted FDA approval as medical devices. In 1979 the FDA approved non-invasive devices using pulsed electromagnetic fields designed to stimulate bone growth. In 1991, PEMF Therapy was approved in the US for adjunctive use in the palliative treatment of postoperative pain and edema in superficial soft tissue. In 2004, pulsed electromagnetic field system was approved by FDA as an adjunct to cervical fusion surgery in patients at high risk for non-fusion. The use of PEMF stimulation has been found to be safe. It has also been proven safe and effective in treatment of delayed union in long bone fractures and patients at a risk of non-union following spinal fusion surgeries. Magnetic and electromagnetic fields are now recognized by the 21st century medicine as real physical entities that promise the healing of various health problems. CE and ISO approval in Europe * FDA registration in the U.S Call for price: (718) 930-5152
POLIMAG 2 provides low-frequency, low-intensity pulsed electromagnetic fields. PEMF Therapy has been proven clinically to help improve the efficacy of medical protocols of patients with acute and chronic cardio-vascular, broncho-pulmonary, neurological, musculoskeletal, immune disorders...